A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
NCT ID: NCT02954094
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
10000 participants
OBSERVATIONAL
2016-12-31
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Target PharmaSolutions, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banner University Medical Center
Phoenix, Arizona, United States
University of Arkansas
Little Rock, Arkansas, United States
University of Southern California/Norris Comprehensive Cancer Center
Los Angeles, California, United States
Stanford University
Palo Alto, California, United States
California Liver Research Institute
Pasadena, California, United States
University of California-Davis
Sacramento, California, United States
University of California
San Francisco, California, United States
Georgetown University
Washington D.C., District of Columbia, United States
Gastro Florida
Clearwater, Florida, United States
University of Florida Hepatology Research at CTRB
Gainesville, Florida, United States
University of Florida Health Gastroenterology
Jacksonville, Florida, United States
Schiff Center for Liver Diseases/University of Miami
Miami, Florida, United States
Tampa General Medical Group
Tampa, Florida, United States
Piedmont Atlanta Hospital
Atlanta, Georgia, United States
Piedmont Cancer Institute
Atlanta, Georgia, United States
Emory University Hospital
Atlanta, Georgia, United States
Northwestern University Division of Gastroenterology and Hepatology
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Tulane University
New Orleans, Louisiana, United States
Mercy Medical Center, GI Research
Baltimore, Maryland, United States
Johns Hopkins University
Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Henry Ford Health System
Detroit, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
Southern Therapy and Advanced Research (STAR) LLC
Jackson, Mississippi, United States
Saint Louis University
St Louis, Missouri, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Rutgers-Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Northwell Health - Center for Liver Diseases
Manhasset, New York, United States
NYU Langone Health
New York, New York, United States
Weill Cornell Medical College
New York, New York, United States
Columbia University
New York, New York, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Center for Liver Disease and Transplant at CMC
Charlotte, North Carolina, United States
Providence Health & Services Cancer Clinical Trials
Portland, Oregon, United States
Penn State Hershey Medical Center
Hershey, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Vanderbilt University Medical Center - GI Research Office
Nashville, Tennessee, United States
Clinical Research Institute@ Methodist Dallas Medical Center
Dallas, Texas, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Baylor Scott & White All Saints
Fort Worth, Texas, United States
Research Specialists of Texas
Houston, Texas, United States
University of Virginia
Charlottesville, Virginia, United States
Bon Secours Liver Institute of Virginia
Richmond, Virginia, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Harborview Medical Center
Seattle, Washington, United States
Wenatchee Valley Hospital & Clinics
Wenatchee, Washington, United States
University of Wisconsin
Madison, Wisconsin, United States
CHU de Nice - Hôpital L'Archet 2
Nice, , France
Hôpitaux Universitaires Paris Centre
Paris, , France
Universitätsklinikum Aachen
Aachen, , Germany
Charité - Universitätsmedizin Berlin
Berlin, , Germany
Universitätsklinikum Düsseldorf
Düsseldorf, , Germany
Universitätsklinikum Frankfurt
Frankfurt, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Universitätsklinikum Leipzig
Leipzig, , Germany
Universitätsklinikum Magdeburg
Magdeburg, , Germany
Universitätsmedizin Mainz
Mainz, , Germany
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, , Italy
A.O.U.P. di Palermo
Palermo, , Italy
Humanitas Mirasole IRCCS
Rozzano, , Italy
IRCCS "Casa Sollievo della Sofferenza"
San Giovanni Rotondo, , Italy
Hospital Puerta de Hierro Majadahonda
Madrid, , Spain
Clínica Universidad de Navarra
Pamplona, , Spain
Hospital Universitario Marques de Valdecilla
Santander, , Spain
Hospital Universitario Virgen del Rocío
Seville, , Spain
Hospital Universitario Politècnic La Fe
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cabrera R, Singal AG, Colombo M, Kelley RK, Lee H, Mospan AR, Meyer T, Newell P, Parikh ND, Sangro B, Reddy KR, Watkins S, Zink RC, Di Bisceglie AM. A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC. Hepatol Commun. 2020 Dec 21;5(3):538-547. doi: 10.1002/hep4.1652. eCollection 2021 Mar.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TARGET-HCC
Identifier Type: -
Identifier Source: org_study_id